¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"urine screening"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
¿µ¹® screening ÇÑ±Û °Ë»ö, ¼±º°
¼³¸í   
  1. º¸±â¿¡´Â °Ç°­ÇÑ °Í°ú °°ÀÌ º¸À̸鼭 Áúº´¿¡ °É·ÁÀÖ´Ù°í »ý°¢µÇ´Â »ç¶÷µéÀ» °ñ¶ó³»±â À§ÇÑ °Ë»ç. Áúº´ÀÇ Áø´ÜÀ» ÀǵµÇÑ °ÍÀº ¾Æ´Ï°í ´Ù¼öÀÇ ¼öÀüÀÚ Áß¿¡¼­ ºñ±³Àû °£´ÜÇÑ ¹æ¹ýÀ¸·Î ÀǽÉÀÌ °¡´Â ÀÚ¸¦ °ñ¶ó³»´Â °ÍÀ» ¸ñÀûÀ¸·Î ÇÑ´Ù. ¼±ÃâµÈ Àڴ ´õ¿í »ó¼¼ÇÑ °Ë»ç¸¦ ¹ÞÀ» Çʿ䰡 ÀÖ´Ù. 2. ½ÃÇèÀ̳ª °Ë»ç¿Í °°Àº ¿¹ºñÀû ÀýÂ÷, Á¶»ç°¡ ´õ ÇÊ¿äÇÑ Àå¾ÖÀÇ °¡Àå Æ¯Â¡ÀûÀΠ¡Èĸ¦ Ã£¾Æ³»±â À§ÇØ ½ÃÇàÇÑ´Ù. 3. Áý´Ü¼±º°°Ë»ç, °íÇ÷¾Ð°ú °°Àº Æ¯Á¤º´À̳ª Àå¾Ö¸¦ Ã£¾Æ³»±â À§ÇØ Å« Ç¥º»À» ÀÌ¿ëÇϴ °Ë»ç.
¿µ¹® urine ÇÑ±Û ¿ÀÁÜ
¼³¸í   
  ÄáÆÏÀ» ÅëÇØ »ý¼ºµÇ¾î ¿ä°üÀ» ÅëÇØ ¿î¹ÝµÇ°í ¹æ±¤¿¡ Àú·ùµÇ¾ú´Ù°¡ ¿äµµ¸¦ ÅëÇØ Ã¼¿Ü·Î ¹èÃâµÇ´Â ¾×ü. ÄáÆÏÀÇ Å丮¿¡¼­ º¸¿ì¸¸ÁָӴϷΠ¿©°úµÈ ¿©°ú¾×ÀÌ ´¢¼¼°üÀ» Áö³ª´Â µ¿¾È ÇÊ¿äÇÑ ¹°ÁúÀº ÀçÈí¼öµÇ°í ºÒÇÊ¿äÇÑ ¹°ÁúÀº ºÐºñµÇ¾î ÃÖÁ¾ÀûÀΠ¿ÀÁÜÀ» Çü¼ºÇÏ°í ¿øÀ§´¢¼¼°ü°ú ÁýÇÕ°ü¿¡ À̸£·¯ ÇÊ¿äÇÑ ¸¸Å­ÀÇ ¼öºÐÀ» aldosterone°ú ADH¸¦ ÅëÇØ Èí¼öÇϹǷνᠿÏÀüÇÑ ¿ÀÁÜÀ» Çü¼ºÇÑ´Ù. ÀÌ·¸°Ô Çü¼ºµÈ ¿ÀÁÜÀº ÀÏ´Ü ¹æ±¤¿¡¼­ ÀúÀåµÇ´Âµ¥ ¿äÀǰ¡ ´À²¸Áú¶§ ºÎ±³°¨½Å°æÀÇ Áö¹è¸¦ ¹Þ´Â ¹è´¢±Ù°ú ±³°¨½Å°æÀÇ Áö¹è¸¦ ¹Þ´Â ¹æ±¤Á¶ÀÓ±ÙÀÇ ÀûÀýÇÑ Çù·ÂÀ» ÅëÇØ Ã¼¿Ü·Î ¹è¼³µÇ°Ô µÈ´Ù.
  
  ¿ÀÇü Ç÷¾×Çü(O type blood group)
  
  Ç÷¾×ÇüÀº ÀûÇ÷±¸¿¡ Á¸ÀçÇϴ Ç׿ø(¸é¿ªÇö»óÀ» ÀÏÀ¸Å°´Â ¾î¶² ¹°Áú. À̰ÍÀº ³»ºÎ¹°ÁúÀÏ ¼öµµ ÀÖ°í, ¿ÜºÎ¿¡¼­ µé¾î¿Â ¹°ÁúÀÏ ¼öµµ ÀÖ´Ù)°ú Ç÷Àå(Ç÷¾×³»¿¡¼­ Ç÷±¸¼¼Æ÷¸¦ »« ³ª¸ÓÁö)³»¿¡ Á¸ÀçÇϴ Ç×ü(¸é¿ªÇö»ó¿¡ ÀÇÇØ »ý°Ü³­ °ÍÀ¸·Î µé¾î¿Â Ç׿øÀ̳ª È¤Àº ¿ø·¡ Á¸ÀçÇϴ Ç׿ø¿¡ ´ëÇØ Ç׿ø-Ç×ü¹ÝÀÀÀ» ÀÏÀ¸Å²´Ù)¿¡ ÀÇÇØ °áÁ¤µÈ´Ù. ÀÌ·± Ç÷¾×Çü¿¡´Â ¼ö½Ê°¡Áö°¡ ÀÖÁö¸¸, ½ÇÁ¦·Î »ý¸íÀ» À§ÇùÇÒ¸¸ÇÑ Áß¿äÇÑ Ç÷¾×ÇüÀ¸·Î´Â A, B, O, AB·Î ³ª´©´Â ABOÇ÷¾×Çü°ú Rh£«/£­·Î ³ª´©¾î RhÇ÷¾×ÇüÀÌ ÀÖ´Ù. OÇüÀº Ç׿øÀº ¾øÀ¸¸ç, anti-B, anti-A Ç×ü¸¦ °¡Áö°í ÀÖ´Ù. µû¶ó¼­ À̻󿡼­ »ìÆìº» ¹Ù¿¡ µû¶ó ¼öÇ÷°¡´É¼º¿©ºÎ¸¦ º¸¸é, °¢ Çü¿¡ ¸Â´Â ÇüÀÇ Ç÷¾×Àº ¾ðÁ¦³ª ¼öÇ÷ÀÌ °¡´ÉÇÏÁö¸¸, ¼öÇ÷À» Çϴ ÂÊÀÇ Ç÷¾×ÀûÇ÷±¸¿¡ ´ëÇØ, ¼öÇ÷À» ¹Þ´Â Ç÷¾×¿¡¼­ ÇØ´çÀûÇ÷±¸¿¡ ´ëÇØ Ç×ü°¡ ¾ø¾î¾ß¸¸, ¼öÇ÷ÀÌ °¡´ÉÇÏ´Ù.
¿µ¹® residual urine ÇÑ±Û ÀÜ´¢
¼³¸í   
  ¿ÀÁÜÀ» ´©°í ³­ µÚ¿¡µµ ¹æ±¤ ¼Ó¿¡ ³²´Â ¿ÀÁÜ. ¹æ±¤¿¡ ±â´É Àå¾Ö°¡ Àְųª ¹æ±¤¸ñ¿¡ º´ÀÌ ÀÖÀ» ¶§ ³ªÅ¸³­´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • cloudy urine
    ȥŹ´¢
  • crude urine
    Èñ¹Ú´¢
  • catheterized urine specimen
    µµ´¢°Ëü
  • Denver Developmental Screening Test
    µ§¹ö¹ß´Þ¼±º°°Ë»ç
  • genetic screening
    À¯Àü¼±º°°Ë»ç
  • hyposthenuric urine
    ÀúºñÁß´¢
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • initial urine
    Ãʱⴢ, ½ÃÀÛ´¢
  • midstream urine
    Áß°£´¢
  • milky urine
    ¾ÏÁ×´¢
  • multiphasic screening
    ´Ù»ó¼±º°°Ë»ç
  • maple syrup urine disease
    ´Üdz½Ã·´´¢º´
  • mass screening
    Áý´Ü¼±º°°Ë»ç
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 12 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • screening
    °Ë»ö, ¼±º°, °Ë»ç
  • neonatal screening
    ½Å»ý¾Æ¼±º°°Ë»ç
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • screening test
    ¼±º°°Ë»ç
  • urine glucose
    ¿ä´ç
  • urine output
    ¼Òº¯¹èÃâ·®
  • split-timed urine protein
    ½Ã°£´ëº°¿ä´Ü¹éÁ¤·®
  • urine
    ¼Òº¯, ¿ÀÁÜ, ¿ä
  • cloudy urine
    ȥŹ´¢
  • initial urine
    Ãʱⴢ, ½ÃÀÛ´¢
  • residual urine
    ÀÜ´¢
  • total volume urine
    Ãѹ财·®
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • antibody-screening cell
    Ç×ü¼±º°Ç÷±¸
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • mass screening
    Áý´Ü°Ë»ç
  • multiphasic screening
    ´Ù´Ü°è¼±º°, ´Ù»ó°ËÁø
  • multiphasic screening test
    ´Ù»ó¼±º°°Ë»ç
  • prescriptive screening
    ó¹æÀû¼±º°¹æ¹ý
  • screening program
    Áý´Ü°ËÁø»ç¾÷, À¯¼Ò°ßÀڹ߰߻ç¾÷
  • screening coordinate recorder
    ÁÖ»ç½ÄÁÂÇ¥±â·Ï±â
  • screening
    °Ë»ö, ¼±º°
  • screening test
    ¼±º°°Ë»ç
  • screening hearing test
    ¼±º°Ã»·Â°Ë»ç
  • catheterized urine specimen
    »ðÀÔµµ´¢°Ë»ç¹°
  • clean catch midstream urine specimen
    û°áäÃëÁß°£´¢°Ë»ç¹°
  • cloudy urine
    ȥŹ´¢
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • U/S osmol ratio => urine/serum osmol ratio
    ¼Òº¯/Ç÷û ¿À½º¸ôºñ
  • anaerobic urine specimen
    Çø±â¼º ¿ä°Ëü
  • hyposthenuric urine
    ÀúÀå´¢
  • initial urine
    Ãʱⴢ.
  • random urine
    ÀÓÀÇ´¢
  • DDST=Denver developmental screening test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç
  • Denver Developmental Screening Test
    µ§¹ö¹ß´ÞÁ¶»ç°Ë»ç(Û¡Ó¹ðàÞÛËþÞÛ)
  • Denver developmental screening test
    µ§¹ö¹ßÀ°¼±º°¹ý.
  • Falcon assay screening test
    ÆÈÄܺм®¼±º°½ÃÇè
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º° °Ë»ç.
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • urine screening
    ¿ä¼±º°
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antibody screening cells
    Ç×ü¼±º°Ç÷±¸
  • antibody screening test
    Ç×ü¼±º°°Ë»ç
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º° °Ë»ç.
  • hearing test, screening
    ¼±º°Ã»·Â°Ë»ç
  • multiphasic health screening
    ´Ù»ó½Ä °Ç°­°ËÁø.
  • multiphasic screening
    ´Ù»ó¼º ¼±º°°Ë»ç.
  • multiphasic screening test
    ´Ù»ó¼º(ËÀË×ËÛ) ½ºÅ©¸®´× Å×½ºÆ®.
  • population screening
    Áý´Ü°ËÁø(̤ËÀ˧̤).
  • prescreening development questionnaire for Denver developmental screening test
  • screening
    ½ºÅ©¸®´×
  • screening [method]
    °Ë»ö(¹ý)
  • screening coordinate recorder
    ÁÖ»ç½ÄÁÂÇ¥±â·Ï±â(ñËÞÛãÒñ¨øöÑÀÒÓÐï).
  • screening hearing test
    ¼±º°Ã»·Â°Ë»ç
  • screening procedure
    ¼±º°ÀÛ¾÷
  • screening program
    Áý´Ü°ËÁø»ç¾÷(̤ËÀ˧̤Ë×Ëâ), À¯¼Ò°ßÀڹ߰߻ç¾÷.
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • mass screening
    Áý´Ü°Ë»ç
  • screening test
    ¼±º°°Ë»ç
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acidification of urine
    ¿ä»ê¼ºÈ­ (èñß«àõûù)
  • maple syrup urine disease
    ´Üdz½Ã·´´¢Áúȯ(Òãòðü´)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • health screening
    °Ç°­Áø´Ü°Ë»ç, °Ç°­¼±º°°Ë»ç
  • residual urine
    ÀÜ´¢
  • screening
    ½ºÅ©¸®ÀÌ´×, ¼±º°¹ý
  • screening test
    ¼±º°°Ë»ç, ¿¹ºñ°Ë»ç
  • urine
    ¿ä, ¿ÀÁÜ, ¼Òº¯
  • urine analysis
    ¿ä°Ë»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MSU maple sugar urine; maple syrup urine; medical studies unit; mid-stream urine; monosodium urate; myoc...
DAST drug abuse screening test; drug and alcohol screening test
ACR Amylase-Creatinine Clearance Ratio
          &...
FENa, FeNa Fractional Excretion of Sodium
  ; VolumeÀÇ °³³äÀ» Á¦°ÅÇÏ¿© Á» ´õ Á¤È®ÇÑ ½ÅÀåÀÇ ³óÃà ´É·ÂÀ» Æò°¡,
 &n...
HCG, hCG Human Chorionic Gonadotropin; »ç¶÷À¶¸ð¼º¼º¼±ÀÚ±ØÈ£¸£¸ó
  1. Placental Glycoprotein Hormone
&nbs...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
FCU First catch urine
FVU First void urine
MSUD Maple Syrup Urine Disease
MSU Midstream urine
U Urine
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • Denver developmental screening test
    µ§¹ö ¹ßÀ° ¼±º° °Ë»ç, µ§¹ö ¹ßÀ° ¼±º°¹ý
    ¹ßÀ° ºÎÁøÀÌ ÀÖ´Â ¿µ¾Æ³ª ÇÐ·É Àü±â ¾Æµ¿À» ½Äº°ÇÏ´Â °Ë»ç¹ý.
  • screening device
    °Ë»ö ±â±â
  • screening examination
    °£ÀÌ °Ë»ç
  • screening history
    °£ÀÌ º´·Â Á¶»ç
  • screening test
    ¼±º° °Ë»ç, ¿¹ºñ °Ë»ç
  • anaerobic urine specimen
    Çø±â¼º ¿ä°Ëü
  • black urine
    Èæ»ö ´¢
  • erythrodontia urine examination
    Àû»ö Ä¡ ´¢ °Ë»ç
  • hyposthenuric urine
    ÀúÀå ´¢
  • maple syrum urine disease
    ´Üdz ³ª¹« ½Ã·´ º´
    Ãø¼â, ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê
  • maple syrup urine disease
    ´Üdz ´ç¹Ð ´¢ Áúȯ
    Ãø¼â ¾Æ¹Ì³ë»ê ´ë»çÀÇ È¿¼Ò °á¼Õ¿¡ ÀÇÇÑ À¯Àüº´À¸·Î, Ç÷Àå ¹× ¿äÁß¿¡¼­ ŰÅä»ê[valine, leucine, isoleucine]ÀÇ ½ÉÇÑ Áõ°¡¸¦ º¼ ¼ö ÀÖ´Ù. ÀÓ»óÀû Ư¡Àº Á¤½Å Áöü ¹ß´Þ Áö¿¬, Æ÷À¯ °ï¶õ, ¿äÃë µîÀÌ´Ù.
  • morning urine
    ¾ÆÄ§ ´¢
  • residual urine
    ÀÜ´¢
  • urine analysis
    ¿ä °Ë»ç, ¼Òº¯ ºÐ¼®
    µ¿ÀǾî=urinalysis.
  • urine-mucoid
    ¿ä ¹«ÄÚÀ̵å
    ¿ä Áß¿¡¼­ º¼ ¼ö ÀÖ´Â Á¡¾× ¸ð¾çÀÇ ¹°Áú.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
cancer, colon: screening and surveillance Colon cancer is both preventable and curable. It is preventable by removing precancerous colon polyps. It is curable if early cancer is surgically removed before cancer spread to other parts of the body. Therefore, if screening and surveillance programs were practiced universally, there would be a major reduction in the incidence and mortality of colon cancer.
(12 Dec 1998)
genetic screening The process of testing individuals to find out if they carry genes for certain known genetic diseases, such as sickle cell anaemia.
(09 Oct 1997)
carrier screening Indiscriminate examination of members of a population to detect heterozygotes for serious disorders and counsel about the risks of marriages with other carriers, and by antenatal diagnosis where a married couple are both carriers; often sacrifices precision to simplicity and is most effectively applied to populations known to be at high risk.
(05 Mar 2000)
mass screening Organised periodic procedures performed on large groups of people for the purpose of detecting disease.
(12 Dec 1998)
vision screening Application of tests and examinations to identify visual defects or vision disorders occurring in specific populations, as in school children, the elderly, etc. It is differentiated from vision tests, which are given to evaluate/measure individual visual performance not related to a specific population.
(12 Dec 1998)
multiphasic screening The simultaneous use of multiple laboratory procedures for the detection of various diseases. These are usually performed on groups of people.
(12 Dec 1998)
prenatal screening Screening for the detection of foetal disease, usually by ultrasound examination or by testing amniotic fluid obtained by amniocentesis. Other screening techniques include testing maternal serum and placental biopsy.
(05 Mar 2000)
cytologic screening A screening for the detection of early disease, usually cancer, through microscopic examination of a cellular specimen by inspecting each cell and structure present, usually at ×100 magnification with a mechanical stage, so that all areas are screened; the findings are evaluated and significant abnormalities are flagged (e.g., by dotting the cover slip) for further evaluation by a cytopathologist. This screening is usually performed by a cytotechnologist, but at times is done by automated machine prescreening.
(05 Mar 2000)
screening Examination of people with no symptoms, to detect unsuspected disease.
(16 Dec 1997)
screening audiometry Rapid measurement of the hearing of an individual or a group against a predetermined limit of normalcy; auditory responses to different frequencies presented at a constant intensity level are tested.
(05 Mar 2000)
screening test Any testing procedure designed to separate people or objects according to a fixed characteristic or property.
(05 Mar 2000)
neonatal screening The identification of selected parameters in newborn infants by various tests, examinations, or other procedures. Screening may be performed by clinical or laboratory measures. A screening test is designed to sort out healthy neonates from those not well, but the screening test is not intended as a diagnostic device, rather instead as epidemiologic.
(12 Dec 1998)
newborn screening Tests of newborns to detect those at increased risk for disorders such as pku (phenylketonuria) and hypothyroidism.
(12 Dec 1998)
Denver Developmental Screening Test A scale used by psychologists and paediatricians to assess the developmental, intellectual, motor, and social maturity of children at any age level from birth to adolescence.
(05 Mar 2000)
differential screening Process in development of a multicellular organism by which cells become specialised for particular functions. Requires that there is selective expression of portions of the genome, the fully differentiated state may be preceded by a stage in which the cell is already programmed for differentiation but is not yet expressing the characteristic phenotype determination.
(18 Nov 1997)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • screening
    üÁúÇϱâ;½É»ç;°¡¸®±â;Â÷Æä
  • urine
    ¼Òº¯
  • urine
    ¿ÀÁÜ;¼Òº¯
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á